Secondary efficacy endpoints
conjunctival
METAPLASIA
Corneal and conjunctival staining scores at 4 weeks were compared with those at baseline. Significant reductions in the corneal staining score (p = 0.002 and p = 0.001 in the AS and PRP groups, respectively) and conjunctival staining score (p = 0.000 and p = 0.001 in the AS and PRP groups, respectively) were observed in both groups (Table Changes in conjunctival impression cytology metaplasia and goblet cell density grades after 12 weeks.△ = Post treatment–Baseline.SD, standard deviation.*Indicates statistical significance.